Get the Stockscreener App
29.37
0.10%
-0.03
After Hours:
29.37
Atricure Inc stock is traded at $29.37, with a volume of 638.32K.
It is down -0.10% in the last 24 hours and down -1.59% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$29.40
Open:
$29.55
24h Volume:
638.32K
Relative Volume:
0.95
Market Cap:
$1.49B
Revenue:
$534.53M
Net Income/Loss:
$-11.45M
P/E Ratio:
-121.82
EPS:
-0.2411
Net Cash Flow:
$48.28M
1W Performance:
+4.08%
1M Performance:
-1.59%
6M Performance:
-20.69%
1Y Performance:
-9.24%
1-Day Range:
$29.24
$29.86
1-Week Range:
$27.26
$29.86
52-Week Range:
$27.26
$43.18
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
29.37 | 1.49B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure to Announce First Quarter 2026 Financial Results - BioSpace
Bull Bear: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARFed Meeting & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Rep. Cisneros Buys AtriCure Shares - National Today
US Market Wrap: Why is AtriCure Inc stock going down2026 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
US Market Wrap: Is AtriCure Inc a top pick in the sectorWeekly Investment Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Atricure stock hits 52-week low at $27.30 amid market challenges - Investing.com Australia
Shorts Report: What are AtriCure Incs recent SEC filings showing2026 Major Catalysts & Technical Pattern Recognition Alerts - baoquankhu1.vn
Assessing AtriCure (ATRC) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Aug Spikes: Why is AtriCure Inc stock going down2026 Price Targets & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Precision Trading with Atricure Inc. (ATRC) Risk Zones - Stock Traders Daily
Value Recap: Is AtriCure Inc a top pick in the sector2026 Volume & Scalable Portfolio Growth Methods - baoquankhu1.vn
AtriCure, Inc. ($ATRC) CEO 2025 Pay Revealed - Quiver Quantitative
AtriCure (NASDAQ: ATRC) 2026 proxy adds 2.25M shares to equity plans - Stock Titan
Should AtriCure’s Q4 Revenue Beat and Cautious Analyst Tone Reshape the ATRC Investment Narrative? - Sahm
AtriCure (NASDAQ:ATRC) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ATRC Should I Buy - Intellectia AI
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Freedom Capital - MarketBeat
ATRC Stock Price, Quote & Chart | ATRICURE INC (NASDAQ:ATRC) - ChartMill
Freedom Capital Markets initiates Articure stock with buy rating By Investing.com - Investing.com India
Freedom Capital Markets initiates Articure stock with buy rating - Investing.com
ATRC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Valuation Update: What are AtriCure Incs recent SEC filings showingQuarterly Market Review & Stock Market Timing Techniques - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
AtriCure stock hits 52-week low at $28.25 amid market fluctuations By Investing.com - Investing.com South Africa
AtriCure stock hits 52-week low at $28.25 amid market fluctuations - Investing.com Australia
AtriCure Inc (ATRC) Stock Price Quote Today & Current Price Chart - Capital.com
AtriCure Inc (ATRC) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Resistance Check: Whats the fair value of AtriCure Inc stock2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
AtriCure Shares Plunge to New 1-Year Low - National Today
AtriCure (NASDAQ:ATRC) Hits New 1-Year LowHere's Why - MarketBeat
Risk Check: Is AtriCure Inc a top pick in the sector2026 Final Week & Consistent Growth Equity Picks - baoquankhu1.vn
Technical Reactions to ATRC Trends in Macro Strategies - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
Projecting the Global Cardiac Ablation Devices Market Size to Expand at a 13.25% CAGR Through 2032, DelveInsight Analysis - Barchart.com
Vanguard disaggregates holdings; AtriCure (NASDAQ: ATRC) shows 0 shares - Stock Titan
Market Outlook: What are the analyst revisions for SMTCIs AtriCure Inc stock a good investment in YEARTake Profit & Safe Capital Investment Plans - baoquankhu1.vn
Trend Report: Is AtriCure Inc in accumulation or distribution phase2026 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
AtriCure, Inc. Experiences Revision in Stock Evaluation Amidst Market Challenges - Markets Mojo
AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? - AOL.com
MACD Signal: Should value investors consider AtriCure Inc2026 Retail Activity & Weekly High Return Forecasts - baoquankhu1.vn
DAFNA Capital Management Sells Axogen Shares in 2025News and Statistics - IndexBox
ATRC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Market Wrap: Is now the right time to enter AtriCure IncPortfolio Return Report & Accurate Intraday Trading Signals - baoquankhu1.vn
AtriCure Chief Scientific Officer Stock SaleMarch 2026 Transaction DetailsNews and Statistics - IndexBox
AtriCure unveils case-based training to build Afib program skills - Traders Union
AtriCure Stock Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Aug Patterns: Is AtriCure Inc undervalued by DCF analysisMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):